Old Web
English
Sign In
Acemap
>
authorDetail
>
David W. Hedley
David W. Hedley
University Health Network
Pancreatic cancer
Medicine
Genetic marker
BRCA2 Protein
Organoplatinum Compounds
3
Papers
301
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
2014
British Journal of Cancer
Talia Golan
Z S Kanji
Ron Epelbaum
N Devaud
Efrat Dagan
S Holter
Dan Aderka
Shani Paluch-Shimon
Bella Kaufman
Ruth Gershoni Baruch
David W. Hedley
Malcolm J. Moore
Eitan Friedman
Steven Gallinger
Show All
Source
Cite
Save
Citations (220)
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer
2012
Investigational New Drugs
Daniel John Renouf
Patricia A. Tang
Pierre Major
Monika K. Krzyzanowska
Bindi Dhesy-Thind
John R. Goffin
David W. Hedley
Lisa Wang
L Doyle
Malcolm J. Moore
Show All
Source
Cite
Save
Citations (22)
The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2
2001
Cell Death & Differentiation
Aaron D. Schimmer
David W. Hedley
Sue Chow
N-A Pham
Avijit Chakrabartty
D Bouchard
T.W. Mak
M R Trus
Mark D. Minden
Show All
Source
Cite
Save
Citations (59)
1